ArticleScientific reports2025
Development of a portable avian influenza virus characterisation system: bringing the inside-out.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Highly pathogenic avian influenza (HPAI) poses a major threat to the world economy and human health; hence, rapid and accurate identification of avian influenza virus (AIV) subtypes is required for effective surveillance and outbreak prevention, particularly in remote or resource-limited settings. Here, we present a portable laboratory system designed to streamline the characterisation of AIV subtypes. This system integrates sample processing, rapid sequencing, and easy to use bioinformatics pipelines to enable characterisation of AIV subtypes, directly from the field. The approach also reduces the chances of samples being degraded, delayed or mixed-up during transport to the laboratory. Equipment for the portable system was first assessed in the laboratory, using AIV isolates with known subtypes, then with swabs collected from several locations in New Zealand. The system was then deployed in the field in Antarctica in December 2024, where it identified HPAI H5N1 in a skua, demonstrating its ability to characterise AIV subtypes rapidly and accurately in situ. This highlights the potential of our portable field system to enhance AIV surveillance in challenging environments and to mitigate the impact of its spread.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.